References
- Bonnet F, Morlat P, Chêne G, Mercié P, Neau D, Chossat I. Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999. HIV Med. 2002; 3(3):195-9. PubMed | Google Scholar
- Etard J, Ndiaye I, Thierry-Mieg M, Guèye N, Guèye P, Lanièce I . Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS Lond Engl. 2006; 20(8):1181-9. PubMed | Google Scholar
- Teklay G, Legesse B, Legesse M. Adverse Effects and Regimen Switch among Patients on Antiretroviral Treatment in a Resource Limited Setting in Ethiopia. J Pharmacovigilance. 2013; 1(4): 115. PubMed | Google Scholar
- Hogg R, Yip B, Kully C, Craib p, O?Shaughnessy v, Schechter T, Montaner G. Improved survival among HIV-infected patients after initiation of triple-drug anti-retroviral regimens. CMAJ. 1999; 160(5):659-665. PubMed | Google Scholar
- WHO/UNAIDS. Report on the global AIDS epidemic, treatment and care. WHO/UNAIDS. 2006. Google Scholar
- FMOH and HAPCO. ART update in Ethiopia. FMOH and HAPCO. 1998. PubMed | Google Scholar
- Hogan D, Salomon J et al. Prevention and treatment of HIV/AIDS in resource limited settings. Bulletin of WHO, Geneva. 2005; 83(2). PubMed | Google Scholar
- Ammassari A, PaolaTrotta M, Mul R. Correlates and Predictors of Adherence to HAART. JAIDS. 2005; 31(3): S123-S127. PubMed | Google Scholar
- FMOH. Disease Prevention and Control Department,
AIDS in Ethiopia, 6th Edition, Addis Ababa. FMOH. 2006. Google
Scholar
- Shah I. Adverse effects of antiretroviral therapy in HIV-1 infected children. J Trop Pediatr. 2006; 52(4):244-8. PubMed | Google Scholar
- Montessori V. Adverse effects of antiretroviral therapy for HIV infection. Canadian Medical Association Journal. 2004; 170 (2): 229-238. PubMed | Google Scholar
- Brinkman K, Smeitink JA, Romijn JA, Reiss P. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet. 1999; 354(9184):1112-5. PubMed | Google Scholar
- Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in large urban clinic: risk factors for neurologic failure and adverse drug reaction. Ann Intern Med. 1999; 131(2):81-7. PubMed | Google Scholar
- Federal Democratic Republic of Ethiopia-Ministry of Health. Harari region Health Sector Development Program IV (2010/11-2014/15) plan Zero draft, Harar. Federal Democratic Republic of Ethiopia-Ministry of Health. 2010. PubMed | Google Scholar
- Habtegiorgis A, Gebreyesus S, Mulugeta E. Evaluation of antiretroviral treatment in two private medical centers in Addis Ababa. Ethiop Med J. 2003; 41(4):345-51. PubMed | Google Scholar
- WHO. Antiretroviral therapy for HIV infection in
adults and adolescents: recommendations for a public
health approach. World Health Organization. 2006. Google
Scholar
- Modayil R, Harugeri A, Parthasarathi G, Ramesh M, Prasad R, Naik V, Giriyapura V. Adverse drug reactions to antiretroviral therapy (ART): an experience of spontaneous reporting and intensive monitoring from ART centre in India. Pharmacoepidemiology and Drug Safety. 2010; 19(3):247-55. PubMed | Google Scholar
- Luma HN, Doualla MS, Choukem SP, Temfack1 E, Ashuntantang G, Joko1 HA, Koulla-Shiro S. Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study. Pan African Medical Journal.2012; 12:87. PubMed | Google Scholar
- Tadesse TW, Mekonnen BA, Tesfaye HW, Tadesse TY. Self-reported adverse drug reactions and their influence on highly active antiretroviral therapy in HIV infected patients: a cross sectional study. BMC Pharmacology and Toxicology.2014; 15:32. PubMed | Google Scholar
- Masenyetse L, Manda S, Mwambi H. An assessment of adverse drug reactions among HIV positive patients receiving antiretroviral treatment in South Africa. AIDS Research and Therapy. 2015; 12:6. PubMed | Google Scholar
- Agu KA, Oparah AC. Adverse drug reactions to antiretroviral therapy: Results from spontaneous reporting system in Nigeria. Perspect Clin Res. 2013; 4(2): 117-124. PubMed | Google Scholar
- Sharma A, Vora R, Modi M. Adverse effects of antiretroviral treatment. Indian J Dermatol Venereol Leprol. 2008; 74(3):234-7. PubMed | Google Scholar
- Marfatia Y, Smita M. Adverse Drug Reactions (ADR) due to Anti-retrovirals (ARV): Issues and Challenges. Indian J Sex Transm Dis. 2005; 26(1-2):40-49. PubMed | Google Scholar
- WHO. Patient evaluation and antiretroviral treatment
for adults and adolescents, clinical Protocol for the WHO European Region
(2012 revision). World Health Organization. 2012. Google
Scholar
- Chang KH, Kim JM, Song YG, Hong SK, Lee HC, Lim SK. Does race protect an oriental population from developing lipodystrophy in HIV-infected individuals on HAART? The Journal of Infection. 2002; 44(1):33-8. Google Scholar
- Wester CW. Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial. Journal of Acquired Immune Deficiency Syndromes. 2007; 46(3):318-22. PubMed | Google Scholar
- Van Griensven J, De Naeyer L, Mushi T, Ubarijoro S, Gashumba D, Gazille C, Zachariah R. High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2007; 101(8):793-8. PubMed | Google Scholar
- Abdissa SG, Fekade D, Feleke Y, Seboxa T, Diro E. Adverse drug reactions associated with antiretroviral treatment among adult Ethiopian patients in a tertiary hospital. Ethiop Med J. 2012; 50(2):107-13. PubMed | Google Scholar
- Nuesch R, Srasuebku P, Ananworanich J, Ruxrungtham K, Phanuphak P, Duncombe C. Monitoring the toxicity of antiretroviral therapy in resource limited settings: a prospective clinical trial cohort in Thailand. Journal of Antimicrobial Chemotherapy. 2006; 58:637-644. PubMed | Google Scholar